Scarica l'app Stockscreener
20.51
9.01%
-2.03
Dopo l'orario di chiusura:
20.95
0.44
+2.15%
Precedente Chiudi:
$22.54
Aprire:
$21.51
Volume 24 ore:
40,439
Relative Volume:
0.72
Capitalizzazione di mercato:
$900.21M
Reddito:
-
Utile/perdita netta:
-
Rapporto P/E:
-
EPS:
-
Flusso di cassa netto:
-
1 W Prestazione:
-10.40%
1M Prestazione:
-15.25%
6M Prestazione:
-52.50%
1 anno Prestazione:
+201.17%
Intervallo 1D:
$20.10
$22.25
Intervallo di 1 settimana:
$20.10
$24.24
Portata 52W:
$5.89
$55.65
Anbio Biotechnology Stock (NNNN) Company Profile
Nome
Anbio Biotechnology
Settore
Industria
Telefono
-
Indirizzo
-
Compare NNNN vs ISRG, BDX, ALC, MDLN, RMD
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
NNNN
Anbio Biotechnology
|
20.51 | 900.21M | 0 | 0 | 0 | 0.00 |
|
ISRG
Intuitive Surgical Inc
|
472.16 | 167.68B | 10.06B | 2.88B | 2.49B | 7.876 |
|
BDX
Becton Dickinson Co
|
159.36 | 45.33B | 21.92B | 1.76B | 2.63B | 6.1223 |
|
ALC
Alcon Inc
|
77.32 | 37.69B | 10.40B | 980.00M | 1.61B | 1.9749 |
|
MDLN
Medline Inc
|
41.46 | 33.65B | 28.43B | 1.16B | 1.26B | 1.4457 |
|
RMD
Resmed Inc
|
230.84 | 33.63B | 5.40B | 1.49B | 1.78B | 10.12 |
Anbio Biotechnology Borsa (NNNN) Ultime notizie
Oncocyte (NASDAQ:IMDX) versus Anbio Biotechnology (NASDAQ:NNNN) Head-To-Head Review - Defense World
Anbio Biotechnology and Oncocyte Compared in Financial Analysis - National Today
Head-To-Head Analysis: Oncocyte (NASDAQ:IMDX) & Anbio Biotechnology (NASDAQ:NNNN) - Defense World
Financial Analysis: Oncocyte (NASDAQ:IMDX) and Anbio Biotechnology (NASDAQ:NNNN) - Defense World
Anbio Biotechnology Stock Quote, Share Price, News and Analysis - Longbridge
Anbio Biotechnology (NASDAQ:NNNN) vs. Oncocyte (NASDAQ:IMDX) Critical Comparison - Defense World
TechTarget (TTGT) to Release Earnings on Wednesday - Defense World
Head to Head Contrast: Oncocyte (NASDAQ:IMDX) & Anbio Biotechnology (NASDAQ:NNNN) - Defense World
Anbio Biotechnology: Improved Margins, Still Priced For Growth That Isn't Showing Up - Seeking Alpha
NNNN Financials: Income Statement, Balance Sheet & Cash Flow - Stock Titan
Oncocyte (NASDAQ:IMDX) versus Anbio Biotechnology (NASDAQ:NNNN) Head to Head Contrast - Defense World
NNNN Technical Analysis & Stock Price Forecast - Intellectia AI
NNNN Should I Buy - Intellectia AI
Anbio Biotechnology (NNNN) Stock Analysis: Navigating Volatility in the Medical Instruments Sector - DirectorsTalk Interviews
Critical Comparison: Oncocyte (NASDAQ:IMDX) vs. Anbio Biotechnology (NASDAQ:NNNN) - Defense World
Anbio Biotechnology Outperforms Oncocyte in Head-to-Head Review - National Today
Celestica Inc. (TSE:CLS) Receives Average Recommendation of “Strong Buy” from Analysts - Defense World
Comparing Anbio Biotechnology (NASDAQ:NNNN) & Oncocyte (NASDAQ:IMDX) - Defense World
Head-To-Head Survey: Oncocyte (NASDAQ:IMDX) and Anbio Biotechnology (NASDAQ:NNNN) - Defense World
Reviewing Anbio Biotechnology (NASDAQ:NNNN) and Oncocyte (NASDAQ:IMDX) - Defense World
Diane Lazzaris Sells 2,747 Shares of WESCO International (NYSE:WCC) Stock - Defense World
Anbio Biotechnology and Oncocyte Compared: Which Stock Reigns Supreme? - National Today
Anbio Biotechnology (NNNN) Stock Analysis: What Investors Should Know About This German IVD Innovator - DirectorsTalk Interviews
Anbio Biotechnology prices $8M IPO at $5 per share - MSN
Oncocyte (NASDAQ:IMDX) vs. Anbio Biotechnology (NASDAQ:NNNN) Critical Comparison - Defense World
Anbio Biotechnology Replaces Auditor to Safeguard 2025 Reporting Timeline - TipRanks
Head-To-Head Comparison: Oncocyte (NASDAQ:IMDX) and Anbio Biotechnology (NASDAQ:NNNN) - Defense World
IPO window reopens, med-tech class of 2025 gains 26% - bioworld.com
Head to Head Analysis: Oncocyte (NASDAQ:IMDX) & Anbio Biotechnology (NASDAQ:NNNN) - Defense World
COREwafer Industries Inc. (OTCMKTS:AHIX) Short Interest Up 126.9% in January - Defense World
GRAIL (GRAL) Projected to Post Earnings on Thursday - Defense World
Anbio Biotechnology (NASDAQ:NNNN) Stock Price Up 8.4%Should You Buy? - MarketBeat
Contrasting Oncocyte (NASDAQ:IMDX) & Anbio Biotechnology (NASDAQ:NNNN) - Defense World
Financial Survey: Oncocyte (NASDAQ:IMDX) and Anbio Biotechnology (NASDAQ:NNNN) - Defense World
Financial Comparison: Oncocyte (NASDAQ:IMDX) and Anbio Biotechnology (NASDAQ:NNNN) - Defense World
Anbio Biotechnology and Oncocyte: A Financial Review - National Today
Critical Analysis: Oncocyte (NASDAQ:IMDX) versus Anbio Biotechnology (NASDAQ:NNNN) - Defense World
12 Health Care Stocks Moving In Thursday's Pre-Market Session - Benzinga
Why Anbio Biotechnology Class A Shares Took Off - TipRanks
12 Health Care Stocks Moving In Tuesday's Intraday Session - Benzinga
Anbio Biotechnology Class A Shares Surge After Volatility Pause - TipRanks
Disney, Micron Tech among market cap stock movers on Monday - Investing.com
Why Anbio Biotechnology Class A Shares Are Surging - TipRanks
InvestingPro’s overvalued warning saved investors from 54% Anbio Bio crash By Investing.com - Investing.com South Africa
Anbio Biotechnology (NNNN) Stock Trends and Sentiment 2026 - MarketBeat
Intel, Oracle among market cap stock movers on Monday By Investing.com - Investing.com Nigeria
Anbio Biotechnology Strengthens Board Oversight With Appointment of Michael Zhang as Audit Committee Chair - TipRanks
Anbio Biotechnology Announces Board and Committee Changes, Effective January 21, 2026 - marketscreener.com
Anbio Biotechnology (NNNN) Stock Analysis: A Rollercoaster Year With Growth Potential - DirectorsTalk Interviews
NNNN Forecast — Price Prediction for 2026. Should I Buy NNNN? - Intellectia AI
Industries Limited Rebound Backed by Sentiment ShiftMACD Trading Signals & Technical + Fundamental = Smarter Investing - bollywoodhelpline.com
Anbio Biotechnology Azioni (NNNN) Dati Finanziari
Non sono disponibili dati finanziari per Anbio Biotechnology (NNNN). Controlla altri titoli per ulteriori informazioni.
Reddito
Reddito netto
Flusso di cassa
EPS
0.97%
1.61%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):